CORC  > 中国医学科学院 北京协和医学院
Randomized Phase III trial of afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one prior trastuzumab treatment: LUX-Breast 1
Harbeck, Nadia; Huang, Chiun-Sheng; Hurvitz, Sara; Yeh, Dah-Cherng; Shao, Zhimin; Im, Seock-Ah; Jung, Kyung Hae; Shen, Kunwei; Ro, Jungsil; Jassem, Jacek
2015
会议名称CANCER RESEARCH
会议日期2015-05-01
收录类别CPCI-S
URL标识查看原文
内容类型会议论文
URI标识http://www.corc.org.cn/handle/1471x/6386265
专题中国医学科学院 北京协和医学院
推荐引用方式
GB/T 7714
Harbeck, Nadia,Huang, Chiun-Sheng,Hurvitz, Sara,et al. Randomized Phase III trial of afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one prior trastuzumab treatment: LUX-Breast 1[C]. 见:CANCER RESEARCH. 2015-05-01.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace